Neuroendocrine Carcinoma of the Breast: Current Evidence and Future Perspectives

Neuroendocrine carcinoma of the breast is considered a rare entity, and for this reason there are no data from prospective clinical trials on its optimal management. Early stage tumors are usually treated with the same strategy used for the other types of invasive breast cancer. Anthracycline- and t...

Full description

Saved in:
Bibliographic Details
Published in:Oncologist
Main Authors: Inno, Alessandro, Bogina, Giuseppe, Turazza, Monica, Bortesi, Laura, Duranti, Simona, Massocco, Alberto, Zamboni, Giuseppe, Carbognin, Giovanni, Alongi, Filippo, Salgarello, Matteo, Gori, Stefania
Format: Artigo
Language:Inglês
Published: AlphaMed Press 2016
Subjects:
Breast Cancer
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4709213/
https://ncbi.nlm.nih.gov/pubmed/26659223
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2015-0309
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items